Cardiac Chambers
POCUS-first practical categories are listed first. Formal echo reference values are included where useful.
2.1 Left ventricle
LVIDd
< 3.6 cm: small or underfilled.
3.6–5.6 cm: normal practical range. (Kirkpatrick 2024; Johri 2023 [R-2-05/06])
5.6 cm: dilated. (Kirkpatrick 2024; Johri 2023 [R-2-05/06])
Formal echo reference: approximately 3.9–5.3 cm in women and 4.2–5.9 cm in men. (Lang 2005/2015; Orsinelli 2015 [R-2-01/02/03])
LVIDs
2.2–4.0 cm: normal practical range.
4.0 cm: suggests impaired systolic emptying.
IVSd / LVPWd
0.7–1.1 cm: normal. (Kirkpatrick 2024; Johri 2023 [R-2-05/06])
≥ 1.2 cm: thickened.
≥ 1.5 cm: severely thickened, HCM range. (Stoica 2011 [R-2-07 = R-7-03]; XREF §7)
LVEF qualitative
Good, moderate, or poor.
LVEF quantitative
≥ 55%: preserved; 50–54%: low-normal; 40–49%: mildly reduced; 30–39%: moderately reduced; < 30%: severely reduced. (Kirkpatrick 2024; Johri 2023 [R-2-05/06])
Formal echo reference: approximately 52–72%. (Lang 2005/2015; Orsinelli 2015 [R-2-01/02/03])
Fractional shortening
≥ 25%: normal; < 25%: reduced. (Kirkpatrick 2024; Johri 2023 [R-2-05/06])
Formal echo reference: approximately 25–45%. (Lang 2005/2015; Orsinelli 2015 [R-2-01/02/03])
LV volumes indexed
LV EDV indexed: men 40–80 mL/m²; women 30–70 mL/m². LV ESV indexed: men 20–45 mL/m²; women 15–35 mL/m². (Lang 2005/2015; Orsinelli 2015 [R-2-01/02/03])
2.2 Left atrium
LA anteroposterior dimension
≤ 4.0 cm: normal; 4.1–4.5 cm: mildly enlarged; > 4.5 cm: enlarged. (Kirkpatrick 2024; Johri 2023 [R-2-05/06])
Formal echo reference: approximately 3.0–4.1 cm. (Lang 2005/2015; Orsinelli 2015 [R-2-01/02/03])
LA area
14–22 cm²: normal practical range. (Kirkpatrick 2024; Johri 2023 [R-2-05/06])
LA volume index
≤ 34 mL/m²: normal; > 34 mL/m²: enlarged; supports chronic elevated left atrial pressure. (Lang 2005/2015; Orsinelli 2015 [R-2-01/02/03])
2.3 Right atrium
RA A / RA B dimension
≤ 6.0 cm: normal; > 6.0 cm: enlarged. (Kirkpatrick 2024; Johri 2023 [R-2-05/06])
Formal echo reference: approximately 4.0–6.0 cm. (Lang 2005/2015; Orsinelli 2015 [R-2-01/02/03])
2.4 Right ventricle
RVOT basal dimension
≤ 3.2 cm: normal; > 3.2 cm: dilated. (Kirkpatrick 2024; Johri 2023 [R-2-05/06])
Formal echo reference: approximately 1.7–3.2 cm. (Lang 2005/2015; Orsinelli 2015 [R-2-01/02/03])
RV free-wall thickness
3–5 mm: normal; > 5 mm: thickened. (Kirkpatrick 2024; Johri 2023 [R-2-05/06])
RV end-diastolic area
Men: 19–32 cm²; Women: 16–27 cm². (Lang 2005/2015; Orsinelli 2015 [R-2-01/02/03])
TAPSE
≥ 17 mm: normal; < 17 mm: impaired; < 14 mm: severely impaired. (Kirkpatrick 2024; Johri 2023 [R-2-05/06])
Formal echo reference: approximately 17–26 mm. (Lang 2005/2015; Orsinelli 2015 [R-2-01/02/03])
RVFAC
≥ 35%: normal; < 35%: impaired. (Kirkpatrick 2024; Johri 2023 [R-2-05/06]; Orsinelli 2015 [R-2-03])
RV/LV diameter ratio
< 1: normal; ≥ 1: RV dilation or acute strain. (Kirkpatrick 2024; Johri 2023 [R-2-05/06])
RV/LV area ratio
< 0.6: normal; 0.6–1.0: mild; ≥ 1.0: marked.
RV S′ lateral tissue Doppler
Approximately 9.5–10 cm/s or greater: normal practical range. (Kirkpatrick 2024; Johri 2023 [R-2-05/06])
2.5 Inferior vena cava
IVC diameter
< 1.5 cm: collapsed or small; possible hypovolaemia.
1.5–2.5 cm: normal or intermediate; correlate clinically.
2.1 cm with inspiratory collapse < 50%: formal elevated RAP estimate; standard formal echo RAP approximately 15–20 mmHg. (Lang 2005/2015; Orsinelli 2015 [R-2-01/02/03])
2.5 cm with poor collapse: plethoric or marked POCUS finding; avoid empiric fluids. (Kirkpatrick 2024; Johri 2023 [R-2-05/06])
3.0 cm with minimal collapse: markedly plethoric; late warning. (Kirkpatrick 2024; Johri 2023 [R-2-05/06])
3.5 cm: marked plethora in some protocols; not a universal formal RAP cutoff; interpret as protocol-specific late warning. (Kirkpatrick 2024 [R-2-05])
Collapsibility in spontaneous breathing (Kirkpatrick 2024; Johri 2023 [R-2-05/06])
50%: low CVP; 20–50%: indeterminate; < 20%: high CVP.
Formula: collapsibility index = (Dmax − Dmin) / Dmax × 100.
Distensibility in mechanical ventilation (Kirkpatrick 2024; Johri 2023 [R-2-05/06])
Dmin-based distensibility: (Dmax − Dmin) / Dmin × 100. Common general controlled-ventilation threshold: ≥ 15%. Validation-specific range: approximately 12–21%. An 18% threshold remains appropriate in selected fully ventilated septic shock protocols; it is a validation-specific operating point, not the only standard.
Mean-based variability: (Dmax − Dmin) / [(Dmax + Dmin) / 2] × 100. Common mean-based threshold: 12%.
Do not interchange collapsibility, Dmin-based distensibility, and mean-based variability. (Kirkpatrick 2024 [R-2-05])
POCUS safety rule (Kirkpatrick 2024; Johri 2023 [R-2-05/06]) — IVC > 2.5 cm with poor collapse is plethoric; avoid empiric fluids. IVC > 3.0 cm with minimal collapse is markedly plethoric and is a late warning. IVC > 3.5 cm is not a universal formal RAP cutoff; it is a protocol-specific marker of marked plethora.
Technique (Lang 2005/2015 [R-2-01/02]; Kirkpatrick 2024 [R-2-05]) — Measure from the subcostal long-axis view, approximately 1–2 cm from the RA–IVC junction, perpendicular to the IVC long axis. Assess diameter and respiratory variation. In adults, use a low-frequency phased-array or curvilinear probe. Do not use sustained maximal inspiratory strain or Valsalva-like effort for collapsibility. In fully mechanically ventilated patients without spontaneous breathing activity, use distensibility or mean-based variability instead of collapsibility.
2.6 Aortic root
< 40 mm: normal; ≥ 40 mm: dilated; ≥ 50 mm: aneurysmal. (Kirkpatrick 2024; Johri 2023 [R-2-05/06]; vascular cross-use: Chang 2021 [R-2-09], XREF §8.1/8.2/8.3; caveat: Q&A book text)
Aortic root measurement should be integrated with aortic valve assessment, pericardial effusion, aortic regurgitation, and clinical suspicion for acute aortic syndrome.
2.7 Pitfalls
Misidentifying RV as LV in poor windows.
Overestimating LV function in a hyperdynamic state.
Underestimating RV dilation when chronically enlarged.
Failing to distinguish acute from chronic RV enlargement.
References:
Lang RM, et al. J Am Soc Echocardiogr. 2005;18(12):1441–63. [R-2-01]
Lang RM, et al. J Am Soc Echocardiogr. 2015;28(1):1–39.e14. [R-2-02]
Orsinelli DA, et al. J Am Soc Echocardiogr. 2015;28(7):687–97. [R-2-03]
Kirkpatrick AW, et al. 2024. [J/pp TBC] [R-2-05]
Johri AM, et al. Am J Med. 2023;136(4):621–8. [R-2-06]
Stoica, et al. 2011. [TBC] [R-2-07 = R-7-03]
Chang AC, et al. 2021. [1200 Q&A book; TBC] [R-2-09]